Australian vaccine preventable disease epidemiological review series: measles, 2012–2019
DOI:
https://doi.org/10.33321/cdi.2022.46.38Keywords:
Measles, disease surveillance, immunisation, epidemiology, vaccine preventable diseaseAbstract
Background
Data sources, relevant to measles epidemiology from 2012 to 2019, were reviewed in the context of Australia’s certification, by the World Health Organization in 2014, of the elimination of measles.
Methods
Data on measles notifications, hospitalisations, and deaths were obtained from the National Notifiable Diseases Surveillance System, the National Hospital Morbidity Database, and the Australian Coordinating Registry. Data were analysed by age group, state/territory, Aboriginal and Torres Strait Islander status, genotype, place of acquisition, source of infection (importation status), and vaccination status.
Results
Between 2012 and 2019, there were 1,337 measles notifications (average annual notifications 0.7 per 100,000 population per year) and 425 hospitalisations with measles as principal diagnosis (0.3 per 100,000 population per year) were recorded. The highest annual notification rate was in 2014, when the rate in the Northern Territory was 21.4 per 100,000 population per year. Although notification and hospitalisation rates were highest in infants < 12 months (respectively 5.8 and 2.1 per 100,000 population per year), people aged 10 to 39 years (10–19y: 272 notifications; 20–29y: 347; 30–39y: 266) accounted for 66% of notified cases. Of cases with a known vaccination status, only 20/169 (11.8%) of those aged 1–9 years had received at least one dose of measles-containing vaccine, compared with 215/571 (37.7%) of those aged 10–39 years. Persons born before 1966 (at least 47 years of age during the study period) are likely to have immunity from wild-type measles infection and had the lowest notification rates in each year. Of notified cases, 98.1% were imported or import related, and of the 900 measles viruses genotyped, D8 and B3 accounted for 89.1%.
Conclusion
This review’s findings of low measles incidence, in the presence of robust surveillance and high two-dose measles vaccination coverage, provide evidence of continued elimination of endemic measles in Australia, with almost all cases imported or epidemiologically linked to an imported case. Most cases eligible for vaccination are unvaccinated, which should remain the primary focus for prevention. Potential waning immunity in older age groups requires monitoring. Continued high population immunity and high-quality public health response to cases will be needed to maintain Australia’s elimination status, particularly once international borders reopen.
Downloads
References
Strebel PM, Orenstein WA. Measles. N Engl J Med. 2019;381(4):349–57.
World Health Organization (WHO). Fact sheets: Measles. [Internet.] Geneva: WHO; 5 December2019. [Accessed on 8 April 2021.] Available from: https://www.who.int/news-room/fact-sheets/detail/measles.
Patel MK, Goodson JL, Alexander JP, Kretsinger K, Sodha SV, Steulet C et al. Progress toward regional measles elimination – worldwide, 2000–2019. MMWR Morb Mortal Wkly Rep. 2020;69(45):1700–5.
Williamson KM, Merritt T, Durrheim DN. Australia: an island in a sea of measles. Med J Aust. 2020;213(3):101–3.
Craig AT, Heywood AE, Worth H. Measles epidemic in Samoa and other Pacific islands. Lancet Infect Dis. 2020;20(3):273–5.
Durrheim DN. Measles eradication—retreating is not an option. Lancet Infect Dis. 2020;20(6):e138–41.
WHO. Measles and rubella strategic framework: 2021-2030. Geneva: WHO; 8 November 2020. [Accessed on 8 April 2021.] Available from: https://www.who.int/publications/i/item/measles-and-rubella-strategic-framework-2021-2030.
Chiew M, Dey A, Martin N, Wang H, Davis S, McIntyre PB. Australian vaccine preventable disease epidemiological review series: measles 2000–2011. Commun Dis Intell Q Rep. 2015;39(1):E1–9.
Hagan JE, Kriss JL, Takashima Y, Mariano KML, Pastore R, Grabovac V et al. Progress toward measles elimination – Western Pacific Region, 2013–2017. MMWR Morb Mortal Wkly Rep. 2018;67(17):491–5.
Heywood AE, Gidding HF, Riddell MA, McIntyre PB, MacIntyre CR, Kelly HA. Elimination of endemic measles transmission in Australia. Bull World Health Organ. 2009;87(1):64–71.
Beard FH, Leask J, McIntyre PB. No Jab, No Pay and vaccine refusal in Australia: the jury is out. Med J Aust. 2017;206(9):381–3.
Ward K, Hull BP, Leask J. Financial incentives for childhood immunisation – a unique but changing Australian initiative. Med J Aust. 2013;198(11):590–2.
Hull BP, Beard FH, Hendry AJ, Dey A, Macartney K. “No jab, no pay”: catch-up vaccination activity during its first two years. Med J Aust. 2020;213(8):364–9.
Australian Government Department of Health. National Notifiable Diseases Surveillance System: Public datasets. [Internet.] Canberra: Australian Government Department of Health; 2021. [Accessed on 16 April 2021.] Available from: http://www9.health.gov.au/cda/source/rpt_3.cfm.
Australian Government Department of Health. Measles case definition. [Internet.] Canberra: Australian Government Department of Health; 29 May 2019. [Accessed on 8 April 2021.] Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_measl.htm.
Australian Bureau of Statistics. Childrens immunisation survey, Australia, November 1983. Canberra: Australia Bureau of Statistics; 1984. 30pp.
Lister S, McIntyre PB, Burgess MA, O’Brien ED. Immunisation coverage in Australian children: a systematic review 1990-1998. Commun Dis Intell. 1999;23(6):145–70.
Brotherton J, McIntyre P, Puech M, Wang H, Gidding H, Hull B et al. Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002. Commun Dis Intell Q Rep. 2004;28(Suppl 2):vii–S116.
Hull BP, Dey A, Beard FH, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2013. Commun Dis Intell Q Rep. 2016;40(1):E146–69.
Hull B, Hendry A, Dey A, Macartney K, Beard F. Immunisation Coverage Annual Report, 2019. Commun Dis Intell (2018). 2021;45. doi: https://doi.org/10.33321/cdi.2020.45.18.
MapInfo. MapInfo Pro. version 15.0. Stamford, Connecticut, USA. MapInfo; 2015.
Guerra FM, Crowcroft NS, Friedman L, Deeks SL, Halperin SA, Severini A et al. Waning of measles maternal antibody in infants in measles elimination settings – a systematic literature review. Vaccine. 2018;36(10):1248–55.
Turnbull FM, Burgess MA, McIntyre PB, Lambert SB, Gilbert GL, Gidding HF et al. The Australian Measles Control Campaign, 1998. Bull World Health Organ. 2001;79(9):882–8.
Hull B, Deeks S, Menzies R, McIntyre P. Immunisation coverage annual report, 2007. Commun Dis Intell Q Rep. 2009;33(2):170–87.
Hull BP, Mahajan D, Dey A, Menzies RI, McIntyre PB. Immunisation coverage annual report, 2008. Commun Dis Intell Q Rep. 2010;34(3):241–58.
Najjar Z, Hope K, Clark P, Nguyen O, Rosewell A, Conaty S. Sustained outbreak of measles in New South Wales, 2012: risks for measles elimination in Australia. Western Pac Surveill Response J. 2014;5(1):14–20.
Gidding HF, Gilbert GL. Measles immunity in young Australian adults. Commun Dis Intell Q Rep. 2001;25(3):133–6.
Lambert SB, Morgan ML, Riddell MA, Andrews RM, Kelly HA, Leydon JA et al. Measles outbreak in young adults in Victoria, 1999. Med J Aust. 2000;173(9):467–71.
Kelly HA, Gidding HF, Karapanagiotidis T, Leydon JA, Riddell MA. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign. BMC Public Health. 2007;7:99. doi: https://doi.org/10.1186/1471-2458-7-99.
Department of Health and Human Services (DHHS). Measles outbreak in Brunswick area. [Internet.] Melbourne: Victoria State Government, DHHS; 23 February 2016. [Accessed on 23 June 2021.] Available from: https://www2.health.vic.gov.au/about/publications/policiesandguidelines/cho-alert-measles-outbreak-in-brunswick-area.
Markey P, Lines S. Measles outbreak summary. N T Dis Control Bull. 2014;21(1):23.
Boyd R. Darwin measles outbreak 2019… the first …and only? N T Dis Control Bull. 2019;26(2):3–7.
Chatterji M, Baldwin AM, Prakash R, Vlack SA, Lambert SB. Public health response to a measles outbreak in a large correctional facility, Queensland, 2013. Commun Dis Intell Q Rep. 2014;38(4):E294–7.
ABC news. Albany measles warning remains in place. [Online news article.] Sydney: Australian Broadcasting Corporation; 25 August 2014. [Accessed on 13 July 2021.] Available from: https://www.abc.net.au/news/2014-08-25/measles-warning-remains-for-recent-visitors-to/5694132.
Government of Western Australia Department of Health (WA Health). Measles cluster in Perth metropolitan area update #3. [Internet.] Perth: WA Health; 4 October 2019. [Accessed on 23 June 2021.] Available from: https://ww2.health.wa.gov.au/Media-releases/2019/Measles-cluster-in-Perth-metropolitan-area-update-3.
Hull B, Hendry A, Dey A, Beard F, Brotherton J, McIntyre P. Annual Immunisation Coverage Report 2016. Commun Dis Intell (2018). 2019;43. doi: https://doi.org/10.33321/cdi.2019.43.44.
Hull B, Hendry A, Dey A, Brotherton J, Macartney K, Beard F. Annual Immunisation Coverage Report 2017. Commun Dis Intell (2018). 2019;43. doi: https://doi.org/10.33321/cdi.2019.43.47.
Hull B, Hendry A, Dey A, McIntyre P, Macartney K, Beard F. Immunisation Coverage Annual Report 2018. Commun Dis Intell (2018). 2021;45. doi: https://doi.org/10.33321/cdi.2020.45.17.
Gidding HF, Martin NV, Stambos V, Tran T, Dey A, Dowse GK et al. Verification of measles elimination in Australia: application of World Health Organization regional guidelines. J Epidemiol Glob Health. 2016;6(3):197–209.
Hull BP, Hendry AJ, Dey A, Beard FH, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2014. Commun Dis Intell Q Rep. 2017;41(1):E68–90.
Hull BP, Dey A, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage, 2012. Commun Dis Intell Q Rep. 2014;38(3):E208–31.
Smith J, Banu S, Young M, Francis D, Langfeldt K, Jarvinen K. Public health response to a measles outbreak on a university campus in Australia, 2015. Epidemiol Infect. 2018;146(3):314–8.
Althaus CL, Salathé M. Measles vaccination coverage and cases among vaccinated persons. Emerg Infect Dis. 2015;21(8):1480–1.
Gidding HF, Quinn HE, Hueston L, Dwyer DE, McIntyre PB. Declining measles antibodies in the era of elimination: Australia’s experience. Vaccine. 2018;36(4):507–13.
Gibney KB, Attwood LO, Nicholson S, Tran T, Druce J, Healy J, et al. Emergence of attenuated measles illness among IgG-positive/IgM-negative measles cases: Victoria, Australia, 2008-2017. Clin Infect Dis. 2020;70(6):1060–7.
Australian Government Department of Health. Australian Immunisation Handbook: Measles. [Internet.] Canberra: Australian Government Department of Health; 2019. [Accessed on 8 April 2021.] Available from: https://immunisationhandbook.health.gov.au/vaccine-preventable-diseases/measles.
World Health Organization (WHO) Regional Office for the Western Pacific (WPRO). Regional strategy and plan of action for measles and rubella elimination in the Western Pacific. Manila: WHO WPRO; 2018. Available from: https://iris.wpro.who.int/handle/10665.1/14227.
Brown KE, Rota PA, Goodson JL, Williams D, Abernathy E, Takeda M et al. Genetic characterization of measles and rubella viruses detected through global measles and rubella elimination surveillance, 2016–2018. MMWR Morb Mortal Wkly Rep. 2019;68(26):587–91.
Alexander KE, Wickens M, Fletcher-Lartey SM. Measles elimination in Australia: Hard won, easily lost. Aust J Gen Pract. 2020;49(3):112–4.
Patel MK, Dumolard L, Nedelec Y, Sodha SV, Steulet C, Gacic-Dobo M et al. Progress toward regional measles elimination—worldwide, 2000–2018. MMWR Morb Mortal Wkly Rep. 2019;68(48):1105–11.
Paudel P, Raina C, Zwar N, Seale H, Worth H, Sheikh M et al. Risk activities and pre-travel health seeking practices of notified cases of imported infectious diseases in Australia. J Travel Med. 2017;24(5). doi: https://doi.org/10.1093/jtm/tax044.
MacIntyre CR, Karki S, Sheikh M, Zwar N, Heywood AE. The role of travel in measles outbreaks in Australia – an enhanced surveillance study. Vaccine. 2016;34(37):4386–91.
WA Health. Adult measles vaccination program campaign. [Internet.] Perth: WA Health; 2019. [Accessed on 5 May 2021.] Available from: https://ww2.health.wa.gov.au/Articles/A_E/Campaign-adult-measles-vaccination-program.
McAnulty JM, Ward K. Suppressing the epidemic in New South Wales. N Engl J Med. 2020;382(21):e74. doi: https://doi.org/10.1056/NEJMc2011592.
Bright A, Glynn-Robinson AJ, Kane S, Wright R, Saul N. The effect of COVID-19 public health measures on nationally notifiable diseases in Australia: preliminary analysis. Commun Dis Intell (2018). 2020;44. doi: https://doi.org/10.33321/cdi.2020.44.85.
National Centre for Immunisation Research and Surveillance (NCIRS). COVID-19: Impact on routine childhood vaccination uptake in Australia. Sydney: NCIRS; 18 November 2020. [Accessed on 8 April 2021.] Available from: https://www.ncirs.org.au/covid-19-impact-routine-childhood-vaccination-uptake-australia.
WHO, Strategic Advisory Group of Experts (SAGE) on Immunization. Meeting of the Strategic Advisory Group of Experts on Immunization, October 2020 – conclusions and recommendations. Wkly Epidemiol Rec. 2020;95(48):585–608.
Chiu C, Dey A, Wang H, Menzies R, Deeks S, Mahajan D et al. Vaccine preventable diseases in Australia, 2005 to 2007. Commun Dis Intell Q Rep. 2010;34(Supp):S1–167.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
